ENHO and coronary artery disorder: Its expression has also been demonstrated in the liver, brain, cerebellum, kidneys, heart, pancreas and vascular tissues.10 The ELISA results in this study revealed that salivary and serum adropin levels were substantially higher in EPACS patients than in the controls and stable CAD patients (0.67–0.8 ng/ml).